Personalized melanoma vaccine shows promise in Moffitt clinical trial

A new approach to treating melanoma is giving doctors at Moffitt Cancer Center hope that more patients could avoid seeing the potentially deadly skin cancer return. Moffitt is participating in a Phase 3 clinical trial testing a personalized mRNA vaccine designed specifically for each patient's cancer. Unlike traditional vaccines, which are generally designed to protect people against the same…